225612, Republic of Belarus, Brest region, Drogichin, Lenin's st., 202
Pharmacovigilance
+375 1644 3-17-84
Products catalog
New
Sofosled
RC № 17/08/2722
Trade name: Sofosled
International name: Sofosbuvir/Ledipasvir
ATX code: J05АХ65
Release form: Tablets
Purpose: The drug is used to treat chronic hepatit C. For adult patients.
Packaging: 28 coated tablets
Available on prescription
Download instruction

Composition. Each tablet, coated with a shell, contains:

  • Active substances:
    • Sofosbuvir 400 mg;
    • Ledipasvir (in the form of a solid dispersion containing 50% of lepidavir and 50% of copovidone) - 90 mg;
  • Excipients

Indications for use.

The drug is used to treat chronic hepatitis C in adult patients.

Method of application and dosage.

See the instruction.

Storage conditions and shelf life.

  • Store in a place protected from moisture and light at a temperature of no higher than 25 ° C.
  • Keep out of the reach of children.

Shelf life - 2 year. Do not use after expiry date.

Packaging.

28 tablets, coated with a shell, in a polymer can with a screw cap, with the control of the first autopsy. 1 bank of polymer with a leaflet in a pack of cardboard box.

Take part in the survey
to help us improve
Take part in the survey to help us improve